The effect of correction of sleep-disordered breathing on BP in untreated hypertension

Chest

Volumn 122, Issue 4, 2002, Pages 1125-1132

  Hla, K Mae ^a   Skatrud, James B ^a   Finn, Laurel ^a   Palta, Mari ^a   Young, Terry ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

BP; Hypertension; Sleep apnea; Sleep disordered breathing treatment

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERTENSION; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0036430197     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1125     Document Type: Article

References (30)

1. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157:1746-1752
2. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283:1829-1836
3. Grote L, Plach T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999; 160:1875-1882
4. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384
5. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163:344-348
6. Minemura H, Akashiba T, Yamamoto H, et al. Acute effects of nasal continuous positive airway pressure on 24-h blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37:1009-1013
7. Vogel AJ, van Steenwijk RP, Karemaker JM, et al. Effects of treatment of obstructive sleep apnea on circadian hemodynamics. J Auton Nerv Syst 1999; 77:177-183
8. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16:545-549
9. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure. Hypertension 2000; 35:144-147
10. Wilcox I, Grunstein RR, Hedner JA, et al. Effect of nasal continuous positive airway pressure during sleep on 24-h blood pressure in obstructive sleep apnea. Sleep 1993; 16:539-544
11. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88:2460-2470
12. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles, CA: Brain Research Institute, 1968
13. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: An objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149:149-154
14. Morgan BJ, Dempsey JA, Pegelow DF, et al. Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep 1998; 21:737-746
15. Guilleminault C, Stoohs R, Shiomi T, et al. Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension. Chest 1996; 109:901-908
16. Ryan CF, Lowe AA, Li D, et al. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis 1991; 144:939-944
17. Collop N, Block A, Hellard D. The effect of nightly nasal CPAP treatment on underlying obstructive sleep apnea and pharyngeal size. Chest 1991; 99:855-860
18. Mortimore AL, Douglas NJ. Palatal muscle EMG response to negative pressure in awake sleep apneic and control subjects. Am J Respir Crit Care Med 1997; 156:867-873
19. Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on tensor palatini EMG and upper airway resistance in normal men. J Appl Physiol 1991; 70:2574-2581
20. Wasicko MJ, Hutt DA, Parisi RA, et al. The role of vascular tone in the control of upper airway collapsibility. Am Rev Respir Dis 1990; 141:1569-1577
21. Remsburg S, Launois SH, Weiss JW. Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia. J Appl Physiol 1999; 87:1148-1153
22. Parati G, Rienzo MD, Bonsignore MR, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15:1621-1626
23. Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long term CPAP treatment in sleep apnea: cardiovascular implications. Eur Respir J 1995; 8:222-229
24. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17:61-66
25. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999; 34:309-314
26. Waradekar NV, Sinoway LI, Zwillich CW, et al. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996; 153:1333-1338
27. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100:2332-2335
28. Krieger J, Follenius M, Sforza E, et al. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci 1991; 80:443-449
29. Young T, Finn L, Hla KM, et al. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure. Sleep 1996; 19(suppl):S202-S205
30. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: part 2. Short-term reduction in blood pressure; overview of randomized drug trials in their epidemiological context. Lancet 1990; 335(8693):827-838